604
A. E. M. Mekky and A. S. Al-Bogami
Vol 53
J= 8.4 Hz), 7.79 (d, 4H, ArH, J= 8.4 Hz), 7.99 (d, 4H, ArH,
J=8.4Hz); 13C NMR (DMSO-d6): δ 46.77, 105.93, 116.28,
119.55, 122.69, 124.73, 125.55, 127.18, 130.32, 135.77, 139.17,
144.90, 148.30, 161.52, 188.09; 19F NMR (DMSO-d6): δ ꢀ67.47;
MS: 724 (M+); C38H22F6N6O3: Anal. Calcd: C, 62.99; H, 3.06; N,
11.60. Found: C, 62.88; H, 3.10; N, 11.63%.
J= 7 Hz), 4.12 (q, 4H, 2CH2, J= 7 Hz), 7.24 (d, 4H, ArH,
J= 8.4 Hz), 7.80 (s, 2H, pyridazine-5-CH), 7.90 (d, 4H, ArH,
J= 8.4 Hz), 8.01 (d, 4H, ArH, J= 8.4 Hz), 8.21 (d, 4H, ArH,
J= 8.4 Hz), 8.35 (s, 2H, 2NH, D2O-exchangeable); 13C NMR
(DMSO-d6): δ 14.13, 61.69, 117.66, 121.88, 124.36, 125.35,
125.60, 126.34, 127,95, 129.81, 137.00, 139.97, 142.20,
155.09, 160.79, 161.29, 187.31; 19F NMR (DMSO-d6): δ
ꢀ67.68; MS: 844 (M+); C42H30F6N6O7: Anal. Calcd: C,
6,6′-(4,4′-Oxybis(benzoyl))bis(2-(4-methylphenyl)-2,3-dihy-
dropyridazine-4-carbonitrile) (15b).
Yellow solid, m.p.
195–197°C; IR: ν 2220 (CN), 1711 (CO) cmꢀ1 1H NMR
;
59.72; H, 3.58; N, 9.95. Found: C, 59.63; H, 3.61; N, 9.98%.
(DMSO-d6): δ 2.34 (s, 6H, 2CH3), 4.79 (s, 4H, pyridazine-3-CH2),
7.29 (s, 2H, pyridazine-5-CH), 7.42 (d, 4H, ArH, J= 8.4 Hz), 7.69–
7.74 (m, 8H, ArH), 8.02 (d, 4H, ArH, J=8.4 Hz); 13C NMR
(DMSO-d6): δ 19.85, 44.25, 104.79, 116.38, 120.16, 126.63,
128.38, 130.27, 131.35, 133.37, 135.80, 141.87, 144.56, 161.15,
186.76; MS: 616 (M+); C38H28N6O3: Anal. Calcd: C, 73.92; H,
4.63; N, 13.67. Found: C, 74.01; H, 4.58; N, 13.63%.
Diethyl 6,6′-(4,4′-oxybis(benzoyl))bis(3-imino-2-(4-methyl-
phenyl)-2,3-dihydropyridazine-4-carboxylate) (20d).
Yellow
solid, m.p. 195–197°C; IR: ν 3400 (NH), 1720, 1628 (2CO)
1
cmꢀ1; H NMR (DMSO-d6): δ 1.05 (t, 6H, 2CH3, J = 7 Hz), 2.34
(s, 6H, 2CH3), 4.14 (q, 4H, 2CH2, J = 7 Hz), 7.21 (d, 4H, ArH,
J = 8 Hz), 7.38 (d, 4H, ArH, J = 8 Hz), 7.80 (s, 2H, pyridazine-5-
CH), 7.92–7.98 (m, 8H, ArH), 8.22 (s, 2H, 2NH, D2O-exchange-
able); 13C NMR (DMSO-d6): δ 14.05, 20.24, 61.72, 118.08,
121.26, 125.61, 127.45, 128.95, 129.29, 131,13, 135.48, 136.81,
139.32, 154.38, 160.23, 161.40, 187.99; MS: 736 (M+);
C42H36N6O7: Anal. Calcd: C, 68.47; H, 4.92; N, 11.41. Found: C,
68.40; H, 4.97; N, 11.36%.
General procedure for the synthesis of bis-(3-imino-2,3-
dihydropyridazine) derivatives 20a–f and bis-(ethyl 3-oxo-2,3-
dihydropyridazine-4-carboxylate) derivatives 22a,b.
Silent
reactions: To a suspension of the appropriate bis-arylhydrazonal
derivatives 6a,b (10 mmol) in pyridine (25 mL), active
methylene nitrile compounds 18a–c (20 mmol) or diethyl
malonate 21 (20 mmol), one drop of piperidine was added. The
reaction mixture was refluxed for the time indicated in Table 2.
After completion of the reaction as indicated by TLC, the
solvent was evaporated under reduced pressure, and the
products obtained were triturated with ethanol, collected by
filtration and crystallized from a mixture of DMF/EtOH (1:10)
to give the corresponding compounds 20a–f and 22a,b.
Sonicated reactions: These processes were performed on the same
scale described above for silent reactions. The mixture was irradi-
ated with ultrasound at 50°C for suitable time (Table 2). The ad-
dition or removal of water controlled the temperature of the water
bath. After completion of the reaction, as indicated by TLC mon-
itoring, the products were obtained and purified as described
above in silent reaction.
6,6′-(4,4′-Oxybis(benzoyl))bis(4-benzoyl-3-imino-2-(4-(tri-
fluoromethyl)phenyl)-2,3-dihydropyridazine) (20e).
Yellow
solid, m.p. 231–233°C; IR: ν 3340 (NH), 1658, 1622 (2CO)
cmꢀ1 1H NMR (DMSO-d6): δ 7.18 (d, 4H, ArH, J = 8.4 Hz),
;
7.36 (t, 2H, ArH, J = 8 Hz), 7.49 (t, 4H, ArH, J = 8 Hz), 7.80 (d,
4H, ArH, J = 8 Hz), 7.94 (s, 2H, pyridazine-5-CH), 8.01 (d, 4H,
ArH, J = 8.4 Hz), 8.08 (d, 4H, ArH, J = 8.4 Hz), 8.35 (d, 4H, ArH,
J = 8.4Hz), 8.74 (s, 2H, 2NH, D2O-exchangeable); 13C NMR
(DMSO-d6): δ 118.76, 122.63, 124.18, 125.21, 126.63, 126.76,
128.57, 129.48, 130.25, 131.54, 132.19, 136.97, 137.10, 139.03,
141.62, 159.83, 160.86, 187.60, 191.99; 19F NMR (DMSO-d6): δ
ꢀ67.76; MS: 908 (M+); C50H30F6N6O5: Anal. Calcd: C, 66.08;
H, 3.33; N, 9.25. Found: C, 66.19; H, 3.26; N, 9.19%.
6,6′-(4,4′-Oxybis(benzoyl))bis(4-benzoyl-3-imino-2-(4-methyl-
6,6′-(4,4′-Oxybis(benzoyl))bis(3-imino-2-(4-(trifluoromethyl)
phenyl)-2,3-dihydropyridazine) (20f).
Yellow solid, m.p.
252–254°C; IR: ν 3332 (NH), 1661, 1629 (2CO) cmꢀ1; 1H NMR
(DMSO-d6): δ 2.39 (s, 6H, 2CH3), 7.32 (t, 2H, ArH, J = 8 Hz),
7.40 (t, 4H, ArH, J = 8 Hz), 7.74 (d, 4H, ArH, J = 8.4 Hz), 7.82 (s,
2H, pyridazine-5-CH), 7.94–8.02 (m, 8H, ArH), 8.10 (d, 4H,
ArH, J = 8.4 Hz), 8.32 (d, 4H, ArH, J = 8.4 Hz), 8.69 (s, 2H, 2NH,
D2O-exchangeable); 13C NMR (DMSO-d6): δ 20.16, 118.20,
122.54, 125.11, 126.80, 128.35, 129.40, 129.89, 131.52, 132.03,
132.27, 137.04, 139.10, 140.17, 142.06, 159.73, 160.37, 187.55,
192.17; MS: 800 (M+); C50H36N6O5: Anal. Calcd: C, 74.99; H,
4.53; N, 10.49. Found: C, 74.89; H, 4.57; N, 10.54%.
phenyl)-2,3-dihydropyridazine-4-carbonitrile) (20a).
Yellow
solid, m.p. 265–267°C; IR: ν 3370 (NH), 2220 (CN), 1622 (CO)
cmꢀ1; 1H NMR (DMSO-d6): δ 7.15 (d, 4H, ArH, J= 8.4 Hz), 7.74 (s,
2H, pyridazine-5-CH), 7.86 (d, 4H, ArH, J= 8.4 Hz), 7.99 (d, 4H,
ArH, J= 8.4 Hz), 8.14 (d, 4H, ArH, J= 8.4 Hz), 8.23 (s, 2H, 2NH,
D2O-exchangeable); 13C NMR (DMSO-d6): δ 108.88, 116.50, 118.78,
121.57, 124.87, 125.89, 126.65, 127.06, 129.95, 139.59, 141.62,
143.91, 155.33, 161.42, 188.07; 19F NMR (DMSO-d6): δ ꢀ67.61;
MS: 750 (M+); C38H20F6N8O3: Anal. Calcd: C, 60.80; H, 2.69; N,
14.93. Found: C, 60.69; H, 2.74; N, 14.99%.
Diethyl 6,6′-(4,4′-oxybis(benzoyl))bis(3-oxo-2-(4-(trifluorome-
6,6′-(4,4′-Oxybis(benzoyl))bis(3-imino-2-(4-methylphenyl)-
thyl)phenyl)-2,3-dihydropyridazine-4-carboxylate) (22a).
2,3-dihydropyridazine-4-carbonitrile) (20b).
Yellow solid, m.
p. 288–290°C; IR: ν 3378 (NH), 2231 (CN), 1629 (CO) cmꢀ1
;
Brown solid, mp 153–155°C; IR: ν 1710, 1649, 1630
1H NMR (DMSO-d6): δ 2.38 (s, 6H, 2CH3), 7.14 (d, 4H, ArH,
J = 8 Hz), 7.40 (d, 4H, ArH, J = 8.4 Hz), 7.74 (s, 2H, pyridazine-5-
CH), 7.87–7.90 (m, 8H, ArH), 8.26 (s, 2H, 2NH, D2O-exchange-
able); 13C NMR (DMSO-d6): δ 19.80, 108.84, 115.07, 117.36,
120.93, 127.16, 128.94, 129.07, 131.23, 136.83, 138.48, 143.95,
153.75, 160.87, 188.86; MS: 642 (M+); C38H26N8O3: Anal. Calcd:
C, 71.02; H, 4.08; N, 17.44. Found: C, 71.11; H, 4.04; N, 17.33%.
Diethyl 6,6′-(4,4′-oxybis(benzoyl))bis(3-imino-2-(4-(trifluo-
1
(3CO) cmꢀ1; H NMR (DMSO-d6): δ 1.13 (t, 6H, 2CH3,
J = 7 Hz), 4.19 (q, 4H, 2CH2, J = 7 Hz), 7.26 (d, 4H, ArH,
J = 8.4 Hz), 7.82 (s, 2H, pyridazine-5-CH), 7.94 (d, 4H,
ArH, J = 8.4 Hz), 8.00 (d, 4H, ArH, J = 8.4 Hz), 8.36 (d, 4H,
ArH, J = 8.4 Hz); 13C NMR (DMSO-d6): δ 13.82, 61.75,
118.02, 123.81, 124.36, 127.80, 128.22, 130.01, 131,52,
131.94, 139.51, 142.27, 143.65, 160.59, 161.42, 162.80,
187.46; 19F NMR (DMSO-d6): δ ꢀ67.54; MS: 846 (M+);
C42H28F6N4O9: Anal. Calcd: C, 59.58; H, 3.33; N, 6.62.
Found: C, 59.66; H, 3.27; N, 6.58%.
romethyl)phenyl)-2,3-dihydropyridazine-4-carboxylate) (20c).
Yellow solid, m.p. 178–180°C; IR: ν 3411 (NH), 1713, 1635
1
(2CO) cmꢀ1; H NMR (DMSO-d6): δ 1.04 (t, 6H, 2CH3,
Journal of Heterocyclic Chemistry
DOI 10.1002/jhet